Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 17 | 2000 | 984 | 0.860 |
Why?
|
| Selection, Genetic | 11 | 1999 | 538 | 0.670 |
Why?
|
| Polymorphism, Genetic | 6 | 2000 | 832 | 0.440 |
Why?
|
| Genetic Variation | 8 | 1999 | 1424 | 0.320 |
Why?
|
| Mathematics | 9 | 2000 | 191 | 0.280 |
Why?
|
| Epidural Space | 1 | 2024 | 6 | 0.220 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2024 | 16 | 0.220 |
Why?
|
| Genotype | 11 | 2000 | 1883 | 0.220 |
Why?
|
| Spinal Cord Compression | 1 | 2024 | 47 | 0.220 |
Why?
|
| Genetics, Population | 3 | 1999 | 439 | 0.180 |
Why?
|
| Computer Simulation | 3 | 1994 | 1158 | 0.170 |
Why?
|
| Environment | 2 | 1994 | 233 | 0.150 |
Why?
|
| Genetic Linkage | 4 | 1998 | 620 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 125 | 0.140 |
Why?
|
| Marriage | 2 | 1988 | 25 | 0.130 |
Why?
|
| Genetic Markers | 3 | 1996 | 477 | 0.130 |
Why?
|
| Alleles | 7 | 2000 | 1157 | 0.120 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 27 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2014 | 134 | 0.100 |
Why?
|
| Epistasis, Genetic | 2 | 1994 | 92 | 0.100 |
Why?
|
| Hybridization, Genetic | 1 | 1994 | 107 | 0.100 |
Why?
|
| Benzamides | 1 | 2014 | 248 | 0.100 |
Why?
|
| Drosophila melanogaster | 2 | 1994 | 634 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 240 | 0.100 |
Why?
|
| Piperazines | 1 | 2014 | 296 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2014 | 386 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 2385 | 0.080 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2010 | 107 | 0.080 |
Why?
|
| Models, Statistical | 2 | 1994 | 594 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 1999 | 444 | 0.070 |
Why?
|
| Fertility | 1 | 1989 | 119 | 0.070 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2008 | 21 | 0.070 |
Why?
|
| Population Dynamics | 1 | 1988 | 144 | 0.070 |
Why?
|
| Animals | 11 | 1999 | 28901 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 1999 | 481 | 0.060 |
Why?
|
| Phenotype | 5 | 1994 | 2575 | 0.060 |
Why?
|
| Organ Transplantation | 1 | 2010 | 298 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 1986 | 171 | 0.060 |
Why?
|
| Genes | 1 | 1986 | 307 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 1425 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2024 | 168 | 0.050 |
Why?
|
| Female | 12 | 2024 | 49980 | 0.050 |
Why?
|
| Male | 10 | 2024 | 45792 | 0.050 |
Why?
|
| Gene Frequency | 2 | 1996 | 703 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1994 | 600 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1994 | 909 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2010 | 2603 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 1999 | 236 | 0.030 |
Why?
|
| Adult | 5 | 2024 | 28636 | 0.030 |
Why?
|
| Logistic Models | 1 | 2000 | 1273 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1996 | 131 | 0.030 |
Why?
|
| Birth Weight | 1 | 1996 | 152 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 28299 | 0.030 |
Why?
|
| Abortion, Habitual | 1 | 1996 | 34 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1996 | 46 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1996 | 278 | 0.030 |
Why?
|
| Placenta | 1 | 1996 | 191 | 0.030 |
Why?
|
| Humans | 11 | 2024 | 95992 | 0.030 |
Why?
|
| Reproduction | 1 | 1996 | 204 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1994 | 115 | 0.030 |
Why?
|
| Inbreeding | 1 | 1994 | 48 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2014 | 127 | 0.030 |
Why?
|
| Wings, Animal | 1 | 1994 | 104 | 0.030 |
Why?
|
| Population Density | 1 | 1994 | 70 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2014 | 88 | 0.020 |
Why?
|
| Linear Models | 1 | 1994 | 438 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 250 | 0.020 |
Why?
|
| Body Weight | 1 | 1994 | 460 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 684 | 0.020 |
Why?
|
| Remission Induction | 1 | 2014 | 750 | 0.020 |
Why?
|
| Normal Distribution | 1 | 1992 | 41 | 0.020 |
Why?
|
| Pregnancy | 3 | 1996 | 3239 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 80 | 0.020 |
Why?
|
| Phosphoglucomutase | 1 | 1989 | 3 | 0.020 |
Why?
|
| MNSs Blood-Group System | 1 | 1989 | 4 | 0.020 |
Why?
|
| Rituximab | 1 | 2010 | 132 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 9878 | 0.020 |
Why?
|
| Breeding | 1 | 1988 | 42 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 1988 | 96 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2008 | 303 | 0.020 |
Why?
|
| Models, Psychological | 1 | 1988 | 166 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3359 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3969 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 1978 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1988 | 334 | 0.010 |
Why?
|
| Choice Behavior | 1 | 1986 | 165 | 0.010 |
Why?
|
| Age Factors | 1 | 1989 | 1959 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 2042 | 0.010 |
Why?
|
| Random Allocation | 1 | 1984 | 321 | 0.010 |
Why?
|
| Sibling Relations | 1 | 1983 | 2 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 3115 | 0.010 |
Why?
|
| Child | 1 | 2014 | 7621 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1984 | 340 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 3993 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 7034 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 7224 | 0.010 |
Why?
|
| Connecticut | 1 | 1996 | 26 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1996 | 34 | 0.010 |
Why?
|
| Models, Biological | 1 | 1984 | 1810 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 9228 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 1996 | 72 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 20927 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 10307 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 1723 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 1962 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1996 | 2611 | 0.000 |
Why?
|